***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting final closure mega reverse merger of LAHO/GSCG by October 23rd (within 150 days from binding LOI executed on May 23rd and filed as an 8K on May 28th)
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell equipment, products/supplies and starter stem cell center packages. The Adimarket which is a wholly owned subsidiary of GSCG, recently was granted exclusive rights to outfit a medical center in Belgium. The Adimarket adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.